Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The study record URL now displays a 403 Forbidden error page, replacing the usual study details content. This indicates restricted access to the record rather than changes to the study data.
    Difference
    18%
    Check dated 2026-09-19T22:27:17.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A minor software revision was applied, updating the page metadata from Revision: v3.6.5 to Revision: v3.6.6. The update does not alter study content or visible functionality.
    Difference
    0.1%
    Check dated 2026-08-29T19:18:02.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a site version update. No user-visible changes to study details or navigation are evident.
    Difference
    0.1%
    Check dated 2026-08-08T17:10:54.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.3 to v3.6.4, indicating a minor update to the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-07-25T11:36:31.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, indicating a minor maintenance/update to the site rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-07-04T01:08:00.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.2, replacing the previous v3.6.0, indicating a minor page update. This change does not alter study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-06-26T23:51:07.000Z thumbnail image

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.